NOVEL COMPOUNDS FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES, IMMUNO-ALLERGICAL DISEASES AND ORGAN OR TISSUE TRANSPLANTATION REJECTION

Details for Australian Patent Application No. 2003274605 (hide)

International Classifications

Event Publications

12 February 2004 Complete Application Filed

Priority application(s): 60/415,508 03.10.02 US

27 May 2004 Application Open to Public Inspection

Published as AU-A-2003274605

9 July 2009 Assignment before Grant

New Era Biotech, Ltd. The application has been assigned to Novaremed Ltd Assignments before Grant, Section 113

20 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.